Ranbaxy fights on as Teva's generic Nexium hits US
This article was originally published in Scrip
Executive Summary
The US FDA has approved the first generic version of AstraZeneca's Nexium (esomeprazole magnesium delayed-release capsules) from Teva arm Ivax Pharmaceuticals, confirming Ranbaxy's fears that it had forfeited its 180-day exclusivity for the 20mg and 40mg versions of the product.